- 1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
- 2Nanyang First People's Hospital, Nanyang, China
- 3The First Clinical College of Zhejiang Chinese Medical University, Hangzhou, China
by Zhang, X., Feng, J., Tan, Z., Zhang, H., Hu, H., Zhao, Y., Wu, D., Zhang, Y., Wu, L., Hu, T., Yan, Z., Ye, B., and Liu, W. (2025). Front. Med. 12:1626325. doi: 10.3389/fmed.2025.1626325
Affiliation “The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China” was erroneously listed as the third affiliation, it should be listed as the first affiliation and edited to “The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China”.
Affiliation “Nanyang First People's Hospital, Nanyang, China” was erroneously listed as the first affiliation, it should be listed as the second affiliation.
Affiliation “The First Clinical College of Zhejiang Chinese Medical University, Hangzhou, China” was erroneously listed as the second affiliation, it should be listed as the third affiliation.
Authors Xinhe Zhang, Jia Feng and Zhengwei Tan should be listed as equal contributing authors. “These authors contributed equally to this work” has been added as a footnote.
The original version of this article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: DPE, avatrombopag, Allo-HSCT, TPO-RA, RhTPO
Citation: Zhang X, Feng J, Tan Z, Zhang H, Hu H, Zhao Y, Wu D, Zhang Y, Wu L, Hu T, Yan Z, Ye B and Liu W (2025) Correction: Analysis of the efficacy of avatrombopag for the delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation for aplastic anemia. Front. Med. 12:1696198. doi: 10.3389/fmed.2025.1696198
Received: 31 August 2025; Accepted: 02 September 2025;
Published: 24 September 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Zhang, Feng, Tan, Zhang, Hu, Zhao, Wu, Zhang, Wu, Hu, Yan, Ye and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wenbin Liu, c3p5eWJsb29kQDE2My5jb20=
†These authors have contributed equally to this work